Dallas- OTCPicks.com’s Daily OTC Stocks Newsletter presents a range of the hottest small cap, micro cap and penny stocks trading on the OTC and OTCBB markets. In addition to our Newsletters, OTCPicks.com is quickly becoming the premier community destination for small cap and micro cap traders to meet up and discuss their top stock picks.
Visit http://www.otcpicks.com/hotpicks.htm today to sign up for our Free Daily Email Newsletter and News Alerts.
Sign up for our Free Red Hot Stock Picks List at
http://www.otcpicks.com/hotpicks.htmJoin us on Twitter at
www.twitter.com/otcpicksJoin us on Facebook at
www.facebook.com/otcpicksSHARP HOLDING CORPORATION (OTC: SHAR)
"Up 44.14% on Tuesday"
Sharp Holding Corp., through its subsidiaries, develops marketing and e-finance products and solutions in the United States. It offers HyperCD technology, which is utilized as a delivery vehicle for Internet-enabled promotions. The company also provides SCAN service that broadcasts alerts and critical safety information from law enforcement and emergency management agencies, schools, and hospitals to local community and neighborhood residents. The company is based in Houston, Texas.
PTS INCORPORATED (OTCBB: PTSH)
"Up 29.41% on Tuesday"
PTS, Inc., through its subsidiary, Glove Box, Inc., owns the rights to patented Glove Box system that offers contamination reduction through automated glove dispensing. The Glove Box system dispenses disposable latex gloves. The company also provides various services, including inspections of facilities, production of accessibility reports, consultation, expert witness services, review of policies, and procedures of the client. PTS, Inc. was founded in 1996 and is based in Las Vegas, Nevada.
COMBINATORX INCORPORATED (NASDAQ: CRXX)
"Up 33.33% on Tuesday"
CombinatoRx, Incorporated (CRXX) is pioneering the new field of synergistic combination pharmaceuticals and has a broad product portfolio in phase 2 clinical development. Going beyond traditional combinations, CombinatoRx creates product candidates with novel mechanisms of action striking at the biological complexities of human disease. The lead programs in the CombinatoRx portfolio are advancing into later stage clinical trials based on the strength of multiple positive phase 2a trial results. This portfolio is internally generated from the CombinatoRx proprietary drug discovery technology which provides a renewable and previously untapped source of novel drug candidates. The Company was founded in 2000 and is located in Cambridge, Massachusetts.
About OTCPicks.com
OTCPicks.com is an Internet destination for investors seeking information on smallcap and microcap and penny stocks. The web site features growing micro cap and penny stock companies. We publish a daily Free email newsletter highlighting the most active Pinksheets, OTCBB and penny stocks. To feature a company on our web site please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com.
Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.
Disclosure: OTCPicks.com has not been compensated by any of the companies covered in this release.
OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk.
